Trial Profile
Aliskiren in hypertensive patients with diastolic dysfunction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jun 2011
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Diastolic heart failure; Hypertension
- Focus Therapeutic Use
- 12 Jun 2011 New trial record
- 24 May 2011 Results presented at the 26th Annual Scientific Meeting of the American Society of Hypertension.